Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Profile analysis for assessing in vitro bioequivalence.

Bin Cheng1, Jun Shao

  • 1Department of Statistics, University of Wisconsin, Madison 53706, USA. bcheng@stat.wisc.edu

Journal of Biopharmaceutical Statistics
|November 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of potential matrix metalloproteinase-2 inhibitors from natural products through advanced machine learning-based cheminformatics approaches.

Molecular diversity·2022
Same author

Knockdown of LncRNA NEAT1 inhibits myofibroblast activity in oral submucous fibrosis through miR-760/TPM1 axis.

Journal of dental sciences·2022
Same author

MHBSt<sup>167</sup> induced autophagy promote cell proliferation and EMT by activating the immune response in L02 cells.

Virology journal·2022
Same author

Coexistence of <i>bla</i> <sub>NDM-1</sub> and <i>bla</i> <sub>IMP-4</sub> in One Novel Hybrid Plasmid Confers Transferable Carbapenem Resistance in an ST20-K28 <i>Klebsiella pneumoniae</i>.

Frontiers in microbiology·2022
Same author

A review of the impacts of climate factors on humans' outdoor thermal perceptions.

Journal of thermal biology·2022
Same author

miR-138-5p Inhibits Vascular Mimicry by Targeting the HIF-1<i>α</i>/VEGFA Pathway in Hepatocellular Carcinoma.

Journal of immunology research·2022

This study critiques the 1999 FDA guidance for in vitro bioequivalence studies of nasal sprays. It proposes a statistically sound method for particle size distribution profile analysis, improving therapeutic equivalence assessments.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems
  • Regulatory Science

Background:

  • Therapeutic equivalence for nasal drug products often relies on in vitro bioequivalence studies.
  • Particle size distribution is a critical quality attribute for nasal aerosols and sprays.
  • Current FDA guidance (1999) for profile analysis lacks statistical rigor.

Purpose of the Study:

  • To identify statistical deficiencies in the FDA's 1999 guidance for in vitro bioequivalence profile analysis.
  • To propose a statistically valid method for analyzing particle size distribution data from nasal spray studies.
  • To enhance the reliability of in vitro bioequivalence assessments for locally acting nasal drug products.

Main Methods:

  • Critical review of the statistical methodology in the 1999 FDA guidance for nasal spray in vitro bioequivalence.

Related Experiment Videos

  • Development of a novel statistical approach for profile analysis of particle size distribution data.
  • Application of the proposed method to cascade impaction and multistage liquid impinger data.

    • Main Results:

    • The statistical approach in the 1999 FDA guidance is shown to be inadequate for profile analysis.
    • The proposed statistical method provides a robust framework for evaluating particle size distribution.
    • The new method ensures a more accurate reflection of the active ingredient's availability at the site of action.

    Conclusions:

    • The 1999 FDA guidance requires revision regarding statistical methods for in vitro bioequivalence.
    • A statistically sound profile analysis is crucial for accurate therapeutic equivalence determination of nasal drug products.
    • The proposed statistical method offers a scientifically justified alternative for regulatory submissions.